AARON LAMMERS: Open Payments
NPI 1417407438 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 121 payments from 20 companies in 2025. Trend: 2023 $219 · 2024 $1,877 · 2025 $2,505
Food & beverage: $2,505
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $404 |
| ABBVIE INC. | 17 | $326 |
| Otsuka America Pharmaceutical, Inc. | 10 | $267 |
| Novo Nordisk Inc | 15 | $252 |
| AstraZeneca Pharmaceuticals LP | 7 | $219 |
| PFIZER INC. | 15 | $196 |
| Lundbeck LLC | 9 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $131 |
| Abbott Laboratories | 6 | $98 |
| Exact Sciences Corporation | 5 | $93 |
Products named: REXULTI, CAPLYTA, JARDIANCE, VRAYLAR, UBRELVY, BREZTRI, Wegovy, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
